Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
Positief advies sluisplaatsing ublituximab en mirikizumab
mei 2023 | IBD, Multipele Sclerose